166 related articles for article (PubMed ID: 18264151)
1. [Model for estimation of cardiovascular risk in Norway].
Selmer R; Lindman AS; Tverdal A; Pedersen JI; Njølstad I; Veierød MB
Tidsskr Nor Laegeforen; 2008 Jan; 128(3):286-90. PubMed ID: 18264151
[TBL] [Abstract][Full Text] [Related]
2. The ability of the SCORE high-risk model to predict 10-year cardiovascular disease mortality in Norway.
Lindman AS; Veierød MB; Pedersen JI; Tverdal A; Njølstad I; Selmer R
Eur J Cardiovasc Prev Rehabil; 2007 Aug; 14(4):501-7. PubMed ID: 17667638
[TBL] [Abstract][Full Text] [Related]
3. The SCORE risk model applied to recent population surveys in Norway compared to observed mortality in the general population.
Lindman AS; Selmer R; Tverdal A; Pedersen JI; Eggen AE; Veierød MB
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):731-7. PubMed ID: 17001212
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
5. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
Metcalf PA; Wells S; Scragg RK; Jackson R
N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
[TBL] [Abstract][Full Text] [Related]
7. [Limitations of data for NORRISK].
Selmer R; Lindman AS; Tverdal A; Pedersen JI; Veierød MB; Njølstad I
Tidsskr Nor Laegeforen; 2009 Apr; 129(8):771. PubMed ID: 19373312
[No Abstract] [Full Text] [Related]
8. Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001.
Hartz I; Njølstad I; Eggen AE
Eur Heart J; 2005 Dec; 26(24):2673-80. PubMed ID: 16204260
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a recalibrated Systematic Coronary Risk Evaluation cardiovascular risk chart: results from Systematic Coronary Risk Evaluation Germany.
Hense HW; Koesters E; Wellmann J; Meisinger C; Völzke H; Keil U
Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):409-15. PubMed ID: 18677164
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for cardiovascular diseases and diabetes in disability pensioners aged 40--42 years: a cross-sectional study in Norway.
Hewitt S; Graff-Iversen S
Scand J Public Health; 2009 May; 37(3):280-6. PubMed ID: 19181824
[TBL] [Abstract][Full Text] [Related]
11. Use of oral contraceptives and mortality during 14 years' follow-up of Norwegian women.
Graff-Iversen S; Hammar N; Thelle DS; Tonstad S
Scand J Public Health; 2006; 34(1):11-6. PubMed ID: 16449039
[TBL] [Abstract][Full Text] [Related]
12. Joint impact of smoking and hypertension on cardiovascular disease and all-cause mortality in Japan: NIPPON DATA80, a 19-year follow-up.
Hozawa A; Okamura T; Murakami Y; Kadowaki T; Nakamura K; Hayakawa T; Kita Y; Nakamura Y; Abbott RD; Okayama A; Ueshima H;
Hypertens Res; 2007 Dec; 30(12):1169-75. PubMed ID: 18344621
[TBL] [Abstract][Full Text] [Related]
13. Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland.
Marques-Vidal P; Rodondi N; Bochud M; Pécoud A; Hayoz D; Paccaud F; Mooser V; Waeber G; Vollenweider P
Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):402-8. PubMed ID: 18677163
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cardiovascular risk predicted by different SCORE equations: the Netherlands as an example.
van Dis I; Kromhout D; Geleijnse JM; Boer JM; Verschuren WM
Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):244-9. PubMed ID: 20195155
[TBL] [Abstract][Full Text] [Related]
15. [Cardiovascular screenings in Norwegian counties. Trends in risk pattern during the period 1985-90 among persons aged 40-42 in 4 counties].
Bjartveit K; Stensvold I; Lund-Larsen PG; Graff-Iversen S; Urdal P
Tidsskr Nor Laegeforen; 1991 Jun; 111(17):2072-6. PubMed ID: 1871735
[TBL] [Abstract][Full Text] [Related]
16. Interaction between inflammation and blood viscosity predicts cardiovascular mortality.
Skretteberg PT; Bodegård J; Kjeldsen SE; Erikssen G; Thaulow E; Sandvik L; Erikssen JE
Scand Cardiovasc J; 2010 Apr; 44(2):107-12. PubMed ID: 19670036
[TBL] [Abstract][Full Text] [Related]
17. [Calibrating the SCORE cardiovascular risk chart for use in Spain].
Sans S; Fitzgerald AP; Royo D; Conroy R; Graham I
Rev Esp Cardiol; 2007 May; 60(5):476-85. PubMed ID: 17535758
[TBL] [Abstract][Full Text] [Related]
18. Heart rate and mortality from cardiovascular causes: a 12 year follow-up study of 379,843 men and women aged 40-45 years.
Tverdal A; Hjellvik V; Selmer R
Eur Heart J; 2008 Nov; 29(22):2772-81. PubMed ID: 18820324
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
[TBL] [Abstract][Full Text] [Related]
20. Seasonal variations in mortality caused by cardiovascular diseases in Norway and Ireland.
Eng H; Mercer JB
J Cardiovasc Risk; 1998 Apr; 5(2):89-95. PubMed ID: 9821061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
